Yongtao Ji
Hangzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Antigen Spreading via Localized Administration Enhances Adoptive TCR-T Cell Therapy in Pancreatic Cancer.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: March 15, 2026
Elevated protein lactylation promotes immunosuppressive microenvironment and therapeutic resistance in pancreatic ductal adenocarcinoma.
Journal: The Journal of clinical investigation
Published: September 12, 2024
Protocol for isolating single cells from human pancreatic cancer tissues and analyzing major immune cell populations using flow cytometry.
Journal: STAR protocols
Published: August 29, 2023
Runx3-overexpression cooperates with ex vivo AKT inhibition to generate receptor-engineered T cells with better persistence, tumor-residency, and antitumor ability.
Journal: Journal for immunotherapy of cancer
Published: February 08, 2023
Multi-omics analysis reveals the chemoresistance mechanism of proliferating tissue-resident macrophages in PDAC via metabolic adaptation.
Journal: Cell reports
Published: December 21, 2022
Targeting MFAP5 in cancer-associated fibroblasts sensitizes pancreatic cancer to PD-L1-based immunochemotherapy via remodeling the matrix.
Journal: Oncogene
Published: November 25, 2022
Recent Advancements of Nanotechnology-Based Strategies for Overcoming Tumor Microenvironment Hypoxia.
Journal: Frontiers in bioscience (Landmark edition)
Published: February 08, 2022
Oxygen microcapsules improve immune checkpoint blockade by ameliorating hypoxia condition in pancreatic ductal adenocarcinoma.
Journal: Bioactive materials
Published: October 14, 2021
Showing 1-8 of 8
Last Updated: 09/26/2026